112 related articles for article (PubMed ID: 18487955)
1. uPAR mediates anticancer activity of PEDF.
Dass CR; Choong PF
Cancer Biol Ther; 2008 Aug; 7(8):1262-70. PubMed ID: 18487955
[TBL] [Abstract][Full Text] [Related]
2. Progression of Osteosarcoma from a Non-Metastatic to a Metastatic Phenotype Is Causally Associated with Activation of an Autocrine and Paracrine uPA Axis.
Endo-Munoz L; Cai N; Cumming A; Macklin R; Merida de Long L; Topkas E; Mukhopadhyay P; Hill M; Saunders NA
PLoS One; 2015; 10(8):e0133592. PubMed ID: 26317203
[TBL] [Abstract][Full Text] [Related]
3. Expression of urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor and maspin in oral squamous cell carcinoma: Association with mode of invasion and clinicopathological factors.
Yoshizawa K; Nozaki S; Kitahara H; Kato K; Noguchi N; Kawashiri S; Yamamoto E
Oncol Rep; 2011 Dec; 26(6):1555-60. PubMed ID: 21833477
[TBL] [Abstract][Full Text] [Related]
4. Antipermeability function of PEDF involves blockade of the MAP kinase/GSK/beta-catenin signaling pathway and uPAR expression.
Yang J; Duh EJ; Caldwell RB; Behzadian MA
Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):3273-80. PubMed ID: 20089873
[TBL] [Abstract][Full Text] [Related]
5. Pigment epithelium-derived factor upregulates collagen I and downregulates matrix metalloproteinase 2 in osteosarcoma cells, and colocalises to collagen I and heat shock protein 47 in fetal and adult bone.
Alcantara MB; Nemazannikova N; Elahy M; Dass CR
J Pharm Pharmacol; 2014 Nov; 66(11):1586-92. PubMed ID: 25175851
[TBL] [Abstract][Full Text] [Related]
6. Maspin retards cell detachment via a novel interaction with the urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor system.
Yin S; Lockett J; Meng Y; Biliran H; Blouse GE; Li X; Reddy N; Zhao Z; Lin X; Anagli J; Cher ML; Sheng S
Cancer Res; 2006 Apr; 66(8):4173-81. PubMed ID: 16618739
[TBL] [Abstract][Full Text] [Related]
7. Urokinase and urokinase receptor participate in regulation of neuronal migration, axon growth and branching.
Semina E; Rubina K; Sysoeva V; Rysenkova K; Klimovich P; Plekhanova O; Tkachuk V
Eur J Cell Biol; 2016 Sep; 95(9):295-310. PubMed ID: 27324124
[TBL] [Abstract][Full Text] [Related]
8. Pigment epithelium-derived factor (PEDF)-induced apoptosis and inhibition of vascular endothelial growth factor (VEGF) expression in MG63 human osteosarcoma cells.
Takenaka K; Yamagishi S; Jinnouchi Y; Nakamura K; Matsui T; Imaizumi T
Life Sci; 2005 Nov; 77(25):3231-41. PubMed ID: 15985268
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of uPA/uPAR inhibits intermittent hypoxia-induced epithelial-mesenchymal transition (EMT) in DAOY and D283 medulloblastoma cells.
Gupta R; Chetty C; Bhoopathi P; Lakka S; Mohanam S; Rao JS; Dinh DE
Int J Oncol; 2011 Mar; 38(3):733-44. PubMed ID: 21181094
[TBL] [Abstract][Full Text] [Related]
10. Pigment Epithelium-Derived Factor and its Phosphomimetic Mutant Induce JNK-Dependent Apoptosis and P38-Mediated Migration Arrest.
Konson A; Pradeep S; D'Acunto CW; Seger R
Cell Physiol Biochem; 2018; 49(2):512-529. PubMed ID: 30157491
[TBL] [Abstract][Full Text] [Related]
11. Role of urokinase plasminogen activator and its receptor in metastasis and invasion of neuroblastoma.
Li P; Gao Y; Ji Z; Zhang X; Xu Q; Li G; Guo Z; Zheng B; Guo X
J Pediatr Surg; 2004 Oct; 39(10):1512-9. PubMed ID: 15486896
[TBL] [Abstract][Full Text] [Related]
12. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
Hildenbrand R; Schaaf A
Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
[TBL] [Abstract][Full Text] [Related]
13. Pigment epithelium-derived factor overexpression inhibits orthotopic osteosarcoma growth, angiogenesis and metastasis.
Ek ET; Dass CR; Contreras KG; Choong PF
Cancer Gene Ther; 2007 Jul; 14(7):616-26. PubMed ID: 17479108
[TBL] [Abstract][Full Text] [Related]
14. Laminin receptor mediates anti-inflammatory and anti-thrombogenic effects of pigment epithelium-derived factor in myeloma cells.
Matsui T; Higashimoto Y; Yamagishi S
Biochem Biophys Res Commun; 2014 Jan; 443(3):847-51. PubMed ID: 24342618
[TBL] [Abstract][Full Text] [Related]
15. Urokinase-type plasminogen activator and its receptor in colorectal cancer: independent prognostic factors of metastasis and cancer-specific survival and potential therapeutic targets.
Yang JL; Seetoo Dq; Wang Y; Ranson M; Berney CR; Ham JM; Russell PJ; Crowe PJ
Int J Cancer; 2000 Sep; 89(5):431-9. PubMed ID: 11008205
[TBL] [Abstract][Full Text] [Related]
16. Tumor stroma is the predominant uPA-, uPAR-, PAI-1-expressing tissue in human breast cancer: prognostic impact.
Hildenbrand R; Schaaf A; Dorn-Beineke A; Allgayer H; Sütterlin M; Marx A; Stroebel P
Histol Histopathol; 2009 Jul; 24(7):869-77. PubMed ID: 19475533
[TBL] [Abstract][Full Text] [Related]
17. Production of active pigment epithelium-derived factor inE. coli.
Zhang T; Guan M; Lu Y
Biotechnol Lett; 2005 Mar; 27(6):403-7. PubMed ID: 15834805
[TBL] [Abstract][Full Text] [Related]
18. Pigment epithelium-derived factor (PEDF) binds to caveolin-1 and inhibits the pro-inflammatory effects of caveolin-1 in endothelial cells.
Matsui T; Higashimoto Y; Taira J; Yamagishi S
Biochem Biophys Res Commun; 2013 Nov; 441(2):405-10. PubMed ID: 24161393
[TBL] [Abstract][Full Text] [Related]
19. Maspin regulates hypoxia-mediated stimulation of uPA/uPAR complex in invasive breast cancer cells.
Amir S; Margaryan NV; Odero-Marah V; Khalkhali-Ellis Z; Hendrix MJ
Cancer Biol Ther; 2005 Apr; 4(4):400-6. PubMed ID: 15846059
[TBL] [Abstract][Full Text] [Related]
20. Cell and molecular biology underpinning the effects of PEDF on cancers in general and osteosarcoma in particular.
Chandolu V; Dass CR
J Biomed Biotechnol; 2012; 2012():740295. PubMed ID: 22690122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
